Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice.
about
Development of Novel Vaccines against Enterovirus-71Is a multivalent hand, foot, and mouth disease vaccine feasible?Therapeutic and prevention strategies against human enterovirus 71 infectionExploiting virus-like particles as innovative vaccines against emerging viral infectionsRecombinant tandem multi-linear neutralizing epitopes of human enterovirus 71 elicited protective immunity in miceEvaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn miceSubviral particle as vaccine and vaccine platform.Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development.Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice.Expression of enterovirus 71 virus-like particles in transgenic enoki (Flammulina velutipes).Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.Immunogenicity and protective efficacy of an EV71 virus-like particle vaccine against lethal challenge in newborn mice.EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challengeBioengineering virus-like particles as vaccines.Update on the development of enterovirus 71 vaccines.The application of virus-like particles as vaccines and biological vehicles.Biomedical applications of yeast- a patent view, part one: yeasts as workhorses for the production of therapeutics and vaccines.Enterovirus71 virus-like particles produced from insect cells and purified by multistep chromatography elicit strong humoral immune responses in mice.Yeast as an expression system for producing virus-like particles: what factors do we need to consider?Immunization with truncated envelope protein of Zika virus induces protective immune response in mice.Characterization of human enterovirus71 virus-like particles used for vaccine antigens.Monoclonal neutralizing antibodies against EV71 screened from mice immunized with yeast-produced virus-like particles.Enhanced enterovirus 71 virus-like particle yield from a new baculovirus design.Generation and characterization of a protective mouse monoclonal antibody against human enterovirus 71.Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in mice.Enterovirus D68 virus-like particles expressed in Pichia pastoris potently induce neutralizing antibody responses and confer protection against lethal viral infection in mice.Structure, Immunogenicity, and Protective Mechanism of an Engineered Enterovirus 71-Like Particle Vaccine Mimicking 80S Empty Capsid.
P2860
Q26771247-8672ACD7-9C7E-41F2-88B4-44AE4E1207FEQ27010349-FBABA62F-236F-460E-B84F-9FA8E229671FQ28080796-EEE0CC3D-3CCB-4D62-8B20-8719257C180BQ29365799-981A099E-5A95-49B5-841C-0A4D7C60DBF4Q33646488-2F4CDE27-A7E4-4AAB-A075-B56DD199EC39Q33723474-A98D410E-B5F2-4563-B17D-4323CB41EDB0Q33812653-F34EA803-10C1-42A3-B038-CD5808C67FA8Q33887710-1143C360-A334-42D7-8122-3A55756968A9Q34981056-DD38EEAB-362E-456C-8E54-D0B8BB6F93DFQ35625893-7AD73E31-1F45-4C38-B211-A3B8B8262E46Q35760496-CE38FA20-BC26-42C6-9C8E-1414205D6577Q36256455-90FF3CE4-8E3E-4611-8EE5-598EEB2AABD2Q36496385-4C936892-EBE5-43D2-9A75-E9C599B9178CQ38172045-2E5B63CB-CB9D-41BC-BEB8-B0977A480908Q38225695-3E2CBA1E-9D8D-4EC6-B40D-8C79D693B594Q38603912-5C62BD08-3394-4945-AA84-E69FA6A7F880Q38671575-DDF72E87-E6FA-4E21-AF71-800440BBEF9DQ38845816-AC29165E-B5AF-49A4-87D1-DCB23F5BABBBQ39012245-A6A5F3A5-5C89-4736-B58E-0FF8DB422DE2Q40037937-5532DFEF-72D4-4BDC-A72C-07C19D579D53Q40113232-32AD98F6-B37F-468A-B405-A7EFB64DDB84Q41186949-3ED36FFA-644F-4DAE-921C-317F012CAEA5Q41209873-B7F02A90-3E4B-4DFC-A330-868EB31DA386Q41236688-43A76A9A-1F9D-401E-A8C3-DD2BB6234793Q42265420-556E8E68-228D-42C3-90C8-49BDAFA358E8Q47555463-6F595F49-D23C-486F-8B59-3CB2D2EA1ED0Q47600312-7EC0930B-8EF7-451B-838A-9CD0E4F0A7A4
P2860
Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Virus-like particles for enter ...... tive immune responses in mice.
@en
Virus-like particles for enter ...... tive immune responses in mice.
@nl
type
label
Virus-like particles for enter ...... tive immune responses in mice.
@en
Virus-like particles for enter ...... tive immune responses in mice.
@nl
prefLabel
Virus-like particles for enter ...... tive immune responses in mice.
@en
Virus-like particles for enter ...... tive immune responses in mice.
@nl
P1433
P1476
Virus-like particles for enter ...... ctive immune responses in mice
@en
P2093
Jian-Feng Han
P304
P356
10.1016/J.VACCINE.2013.05.019
P407
P577
2013-05-29T00:00:00Z